RE:RE:RE:New Press Release - Kane Biotech Announces Third Quarter 2024 Financial ResultsCorrect and if I understand well, this upcoming collaboration will, again, be for DispersinB.
He also made a comment, and this is not the first time he does, about the fact that other major players in the wound care area are showing interest for DispersinB.
Things to look for in the weeks before the Holidays (from Kane's latest presentation and video);
1. Pot'l financing...
2. Start of the ACNE trials with UofMiami;
3. First shipment of Revyve wound gel spray;
4. Sales distribution agreement for Canada;
There is also a new product on the Omni website...see the link below;
[url=https://https://www.omnibioinnovations.com/shop/uncategorized/bio-scalp-detoxifier-care-active/]OMNIInnovation scalp detoxifier[/url]
They do not mention the use of Coactiv+ on the bottle or in the description but, looks like it is their first product using KNE technology.
GLTA!